Tiffany Eul Davis Inglis, Chief Medical Officer at SERA PROGNOSTICS, INC. (SERA), sold 486 shares at $2.00 ($972) on 2026-09-10, disclosed to the SEC on 2026-09-11.
Open-market sale of $972 SERA by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.